Top Articles
What’s Behind the Surge in Lab Outreach Sales?
An M&A insider gives her thoughts on why the clinical laboratory market supports such deals
CEO SUMMARY: The recent CHS-Labcorp deal is one of many that highlights a market shift. Clinical lab outreach services, once viewed as strategic assets, are being sold off rapidly as hospitals recenter around core services and offload logistical burdens. This year, 30% of ...
Profitable Collaboration with Pharma Companies
Pharmaceutical companies are after clinical lab specimens and data, which creates opportunities
CEO SUMMARY: Drug discovery efforts by pharmaceutical companies often need a boost from anatomic pathology practices and clinical laboratories. Forward-thinking lab leaders and pathologists can take advantage of their data and expertise to partner with pharma, setting the ...
Former Payer CEO Posts Sharp Comments on LinkedIn
J. Mario Molina, MD, ex-CEO at Molina, says he is not shocked by the current state of affairs
FORMER CEO OF PUBLICLY-TRADED INSURANCE COMPANY MOLINA HEALTHCARE, J. Mario Molina, MD, took to LinkedIn in July offering a sobering perspective on the current state of the private payer industry. Drawing on his 14 years at the helm, Molina remarked, “What’s happening right now does...
Despite Trade Tariffs, IVD Firms Report Upbeat Earnings
For now, it appears diagnostic kit manufacturers are bearing tariffs and policy changes in China
LEADING IN VITRO DIAGNOSTICS (IVD) COMPANIES RECENTLY REPORTED POSITIVE QUARTERLY FINANCIALS despite swirling concerns about trade tariffs and cuts to US federal research grants. It’s not yet clear what the long-term effect of tariffs’ will be on IVD manu...
How Federal Court’s Decision Will Affect Lab Marketing
It’s likely to add costs, but it could potentially open an opportunity for smaller laboratories
MOST MEDICAL PROVIDERS are buyers of healthcare services. But for clinical laboratories, that equation is turned on its head. Labs are medical providers, but since they rarely provide those services directly to patients, they must properly market them to providers to ensure steady sales...
My Green Lab Prepares Full-Scale Entry into Diagnostics
Siemens Healthineers completes new environmental certification in My Green Lab pilot program
AGAINST THE BACKDROP OF REDUCED SUSTAINABILITY INITIATIVES IN THE CORPORATE AND POLITICAL WORLDS, environmental stewardship remained a topic of discussion  at the Association for Diagnostics and Laboratory Medicine’s (ADLM) 2025 conference. Among the more interesting announcements wa...
An Insider’s Observances of Lab Outreach Deals
THERE ARE MANY WAYS TO VIEW CLINICAL LABORATORY OUTREACH ACQUISITIONS and the enormous amount of money changing hands in these deals. From one point of view, those fearful of the continued expansion of national lab giants like Labcorp and Quest Diagnostics may shiver every time one of these companies grabs a new outreach site. ...
Don’t Be at the Mercy of the Tumultuous Healthcare Revolution
Subscribe to The Dark Report for as little as $15.27 per week.
Get the most expert business intelligence for clinical laboratories and pathology groups available today. Subscribe to The Dark Report.
CURRENT ISSUE
Volume XXXII, No. 12 – August 25, 2025
In an exclusive interview, a laboratory industry M&A specialist discusses what’s driving lab outreach sales to national lab companies. Also, The Dark Report analyzes ways in which pathology and clinical labs can profitably partner with pharmaceutical companies.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.